Consistent with our cellular studies, COPS5 KO reduced tumor growth and potentiated tumor growth suppression conferred by sorafenib in BALB/c nude mice bearing HepG2 subcutaneous xenografts, as detected by both tumor volume and weight, which could be offset by ferrostatin‐1 treatment (Figure 3H–J). Here, COPS5 is linked to neoplasm.